Varicella Zoster Virus Infection

10/27/2022 - "Shedding a Light on Acyclovir Pharmacodynamics: A Retrospective Analysis on Pharmacokinetic/Pharmacodynamic Modelling of Acyclovir for the Treatment of Varicella Zoster Virus Infection in Immunocompromised Patients: A Pilot Study."
10/01/2018 - "After an extensive workup, she was diagnosed with a varicella zoster virus infection with involvement of the gastric mucosa, pancreas and lungs for which she was treated with acyclovir. "
08/01/2014 - "Acyclovir is a highly potent inhibitor of varicella-zoster virus infection. "
09/24/2010 - "However, he developed a varicella-zoster virus infection of the twelfth thoracic dermatome requiring intravenous acyclovir treatment. "
03/06/1999 - "Aciclovir (800 mg) can be given in HIV-infected patients who develop non-complicated varicella-zoster virus infection. "

08/01/2016 - "Varicella-zoster virus infection is associated with significant morbidity and mortality in immune-compromised children, despite treatment with antiviral agents. "
11/23/1998 - "[Antiviral treatment of Varicella zoster virus infection]."
10/15/2017 - "Appropriate antiviral therapy should be administered while waiting for confirmation of the diagnosis, so as to reduce the risk of visceral dissemination of the varicella zoster virus infection."
01/01/2021 - "Recent case series and retrospective studies have raised concerns that patients who receive direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection are at increased risk of developing varicella-zoster virus infection (VZV reactivation). "
02/01/2008 - "During the first trimester, primary VZV infection may result in stillbirth or a baby born with the stigmata of the congenital varicella syndrome, while infection in the peripartum period can result in neonatal varicella, which carries a significant mortality rate despite appropriate antiviral therapy. "

06/01/1984 - "These data compare favorably with published data both from the treatment of normal persons with acyclovir and treatment of normal persons with acyclovir and treatment of immunocompromised patients with vidarabine, and they indicate that acyclovir is safe and effective for the treatment of varicella-zoster virus infection in the severely immunocompromised host."
04/01/2000 - "Idoxyuridine, vidarabine, and acyclovir have been used for herpes simplex virus and varicella-zoster virus infection for two decades in Japan. "
12/01/1989 - "Comparison of acyclovir and vidarabine in immunocompromised children with varicella-zoster virus infection."
01/23/1986 - "In a prospective, randomized trial, we compared intravenous acyclovir and vidarabine in the treatment of varicella-zoster virus infection in severely immunocompromised patients who presented within 72 hours of onset of the infection. "
12/01/1988 - "Successful combination therapy with acyclovir and vidarabine for disseminated varicella zoster virus infection with retinal involvement in a patient with B-cell lymphoma and adult T-cell leukemia."

01/01/1985 - "Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine."
11/01/1991 - "Both aciclovir and brivudin are effective in the treatment of immunocompromised children with varicella-zoster virus infection. "
11/01/1991 - "Antiviral therapy of varicella-zoster virus infection in immunocompromised children--a prospective randomized study of aciclovir versus brivudin."

01/15/2010 - "Children 1 month through 5 years of age with or at risk for herpesvirus infection received a single 25 mg/kg dose of extemporaneously compounded valacyclovir oral suspension (n = 57), whereas children 1 through 11 years of age received 10 mg/kg valacyclovir oral suspension twice daily for 3-5 days (herpes simplex virus infection) (n = 28) or 20 mg/kg 3 times daily for 5 days (varicella-zoster virus infection) (n = 27). "
08/01/2009 - "We present two prostate cancer patients, including one with a castration-resistant cancer whose rising serum prostate-specific antigen (PSA) levels showed a remarkable drop after a reactivated varicella-zoster virus infection treated with valaciclovir. "
12/01/2011 - "A 51-year-old woman with human immunodeficiency virus (HIV) infection and end-stage renal disease arrived at the emergency department (ED) with a diffuse rash on the chest and back; she was diagnosed with varicella-zoster virus infection, received one dose of i.v. acyclovir, and was discharged home with a prescription for valacyclovir. "
01/01/2018 - "The discovery of acyclovir and penciclovir has led to the development of a successful systemic therapy for treating herpes simplex virus infection and varicella-zoster virus infection, and the orally available prodrugs, valacyclovir and famciclovir, have improved antiviral treatment compliance. "

05/01/2009 - "Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection."
05/01/2021 - "Successful treatment with famciclovir for varicella zoster virus infection resistant to acyclovir."
01/01/2018 - "The discovery of acyclovir and penciclovir has led to the development of a successful systemic therapy for treating herpes simplex virus infection and varicella-zoster virus infection, and the orally available prodrugs, valacyclovir and famciclovir, have improved antiviral treatment compliance. "

04/01/2016 - "[Fulminant visceral disseminated varicella-zoster virus infection without skin involvement in a patient with autoimmune hemolytic anemia on prednisolone therapy]."
08/01/2001 - "Among the patients without CMV antigenemia and without prednisolone (PSL) therapy for acute GVHD (n = 15), only 3 developed TRT or infections (pneumonia, varicella zoster virus infection and hemolytic uremic syndrome), but all of these episodes were cured without fatality. "

01/01/2018 - "The discovery of acyclovir and penciclovir has led to the development of a successful systemic therapy for treating herpes simplex virus infection and varicella-zoster virus infection, and the orally available prodrugs, valacyclovir and famciclovir, have improved antiviral treatment compliance. "

01/01/2018 - "The discovery of acyclovir and penciclovir has led to the development of a successful systemic therapy for treating herpes simplex virus infection and varicella-zoster virus infection, and the orally available prodrugs, valacyclovir and famciclovir, have improved antiviral treatment compliance. "

09/01/2012 - "Neonatal vaccine-strain varicella-zoster virus infection 22 days after maternal postpartum vaccination."
01/10/2011 - "The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. "
11/01/1984 - "Seroepidemiologic behavior of varicella zoster virus infection in a semiclosed community after introduction of VZV vaccine."
01/01/2008 - "This review offers an overview of varicella zoster virus infection and complications, a summary of the Shingles Prevention Study, and a critical analysis designed to aid the practicing physician who has questions about vaccine administration."
02/01/2021 - "Concerns on Vaccine against Varicella Caused by Varicella-Zoster Virus Infection."

08/29/1988 - "Current therapy of varicella zoster virus infection in immunocompromised patients. "
01/01/2023 - "Visceral disseminated varicella zoster virus infection during non-intensive maintenance therapy in a patient with systemic lupus erythematosus."
01/01/1992 - "Measures for diagnosis, prophylaxis and therapy in the case of congenital varicella syndrome as well as connatal varicella are discussed."
09/01/1982 - "Further complication of varicella-zoster virus infection during anti-leukemia therapy]."
08/01/2013 - "Among patients receiving active therapy these included eight cases of Mycobacterium tuberculosis, eight cases of herpes simplex infection, six cases of oral or esophageal candidiasis, six cases of herpes zoster infection, two cases of varicella-zoster virus infection, two cases of cytomegalovirus or Epstein-Barr virus infection, and one case of Nocardia infection. "

01/01/2008 - "Highly active antiretroviral therapy at the time of primary varicella zoster virus infection was protective against herpes zoster and increased herpes zoster-free survival. "
01/01/2008 - "The use of highly active antiretroviral therapy at the time of primary varicella zoster virus infection decreased the risk of herpes zoster and increased herpes zoster-free survival. "
02/01/2006 - "Forty-four patients (22.7%) experienced an IRIS event at a median of 12 weeks after HAART initiation (IQR, 4-24 weeks after initiation); 22 events (50%) involved genital herpes, 10 (23%) involved genital warts, 4 (9.0%) involved molluscum contagiosum, and 4 (9.0%) involved varicella zoster virus infection. "

01/01/2020 - "Varicella Zoster Virus Infection in Children with Autologous Hematopoietic Cell Transplantation: A Retrospective, Single-Center Study in Korea."
06/01/2009 - "Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group."
02/01/2017 - "Predicting risk factors for varicella zoster virus infection and postherpetic neuralgia after hematopoietic cell transplantation using ordered logistic regression analysis."
04/01/2017 - "Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in children using a relatively short duration of acyclovir prophylaxis: A retrospective study."

07/01/1991 - "Foscarnet is a potentially effective and tolerable antiviral agent for patients with acyclovir-resistant, varicella-zoster virus infection; however, the optimal dosage and duration of therapy require further study, as does the relation between clinical findings and in-vitro susceptibility results."

03/01/1999 - "Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue."
08/01/1994 - "Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children."
02/01/1989 - "[Clinical signs and symptoms, and chemotherapy of varicella zoster virus infection]."
12/01/1987 - "[Chemotherapy of varicella-zoster virus infection]."
01/01/2012 - "Varicella zoster virus infection during chemotherapy in solid cancer patients."